Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rangering i aksjer #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aksjekurs
$30.90
Sist synkronisert: 2026-08-27
Markedsverdi
$1.90B
Endring (1 dag)
1.68%
Endring (1 år)
859.63%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategori

Aksjeprishistorikk for Damora Therapeutics, Inc. (DMRA)
Høyeste sluttskurs: $30.70 den 2026-08-01

Laveste sluttskurs: $375.00 den 2020-10-01
Aksjeprishistorikk for Damora Therapeutics, Inc. fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -18.93%
2025 415.83%
2024 -67.67%
2023 -52.57%
2022 -51.37%
2021 -80.02%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH